The UNC Eshelman School of Pharmacy-PQA-Janssen Postdoctoral Fellowship in Real World Evidence (RWE), Population Health, and Quality Research aims to prepare the fellow for a career in healthcare quality-related outcomes research. The program is designed to develop key competencies and experience in conducting RWE research with a focus on population health and quality-related measures and outcomes, while providing electives for customized training based on candidate interests and sponsor priorities. Graduates will be well-positioned to contribute to RWE, population health, and quality-related research in the pharmaceutical industry.
This two-year fellowship will be based at UNC Eshelman School of Pharmacy (Chapel Hill, NC) for the first 12 months where the fellow will have the opportunity to enroll in and audit relevant courses. For year 2, the fellow will spend 6 months at the Pharmacy Quality Alliance (PQA; Arlington, VA) and 6 months at Janssen with their Scientific Affairs group (Titusville, NJ).
Fellowship Opportunities and Expectations
University of North Carolina – Chapel Hill
Complete didactic training in quality measurement and quality-related research
Actively participate in ongoing Center for Medication Optimization (CMO) research, including retrospective, prospective, and PRO-related research
Conduct, and submit for publication, a self-directed secondary data analysis project with administrative claims from MarketScan®, Medicare, North Carolina Medicaid, and/or Blue Cross Blue Shield of North Carolina
Collaborate on ongoing research with Janssen/PQA
Pharmacy Quality Alliance
Actively participate in ongoing PQA research
Gain exposure to the quality measure lifecycle including conceptualization, specification, testing, endorsement, implementation, and maintenance processes
Learn about financial models in healthcare ecosystem and various value-based payment programs
Explore the role of healthcare quality measurement organizations in the greater Washington, D.C. area
Understand how healthcare stakeholders, including life science industry, engage with quality organizations, like PQA and others, to advance and align quality strategies
Janssen Scientific Affairs
Actively participate in real world evidence, population health, and quality research & performance measurement within the life science industry
Build quality considerations into endpoint decisions for pre-approval trials
Include quality and policy considerations in RWE generation
Gain exposure to how patient-reported outcomes (PROs) are incorporated into data and evidence generation from regulatory, real-world and policy perspectives
Translate scientific research for non-scientific policy audiences
Use data and evidence to support above-product external policy discussions related to improving quality of care for patients in a given therapeutic area
UNC is an equal opportunity and affirmative action employer. All qualified applicants will receive consideration for employment without regard to age, color, disability, gender, gender expression, gender identity, genetic information, national origin, race, religion, sex, sexual orientation, or status as a protected veteran.
Candidates must hold a doctoral degree (PhD, PharmD, MD, etc.) from an accredited program and be eligible to live and work in the US. Candidates should possess direct knowledge in epidemiology, health services research, comparative effectiveness research, and patient-centered outcomes research (or an equivalent area of focus). Candidates should also demonstrate proficiency in SAS, Stata, SQL, and/or R.
Internal Number: PDS002839
About UNC Eshelman School of Pharmacy
The UNC Eshelman School of Pharmacy is part of the University of North Carolina at Chapel Hill, a major research university with a large teaching hospital and schools of medicine, public health, nursing and dentistry.
UNC-Chapel Hill anchors one corner of North Carolina’s famed Research Triangle Park, which hosts an abundance of pharmaceutical, biotech and health-care companies. This environment offers abundant opportunities for collaboration in research, education and patient care with partners in academia, industry and health care. The school has specialized research centers pursuing advances in drug discovery, nanotechnology in drug delivery and cancer treatment, pharmacogenomics and medication optimization